Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Cervical Cancer and HPV Research

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 3,521 works 203 author topics

Works

3,521 works

  1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study 2010
    OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  2. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study 2018
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  3. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva 2013
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%

    No abstract yet.

  4. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study 2010
    OpenAlex top 1% OpenAlex 99.4%

    OBJECTIVE: To determine whether offering self sampling of cervicovaginal material for high risk human papillomavirus (HPV) testing is an effective screening method for women who do not attend regular cervical screening programmes. DESIGN: Cohort study (the PROHTECT trial). Settings Noord-Holland and Flevoland regions…

  5. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer 2020
    SJR Q2 JCR Q2 OpenAlex top 1% OpenAlex 99.4%

    No abstract yet.

  6. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening 2021
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    BACKGROUND: Only clinically validated HPV assays can be accepted in cervical cancer screening. OBJECTIVES: To update the list of high-risk HPV assays that fulfil the 2009 international validation criteria (Meijer-2009). DATA SOURCES: PubMed/Medline, Embase, Scopus, references from selected studies; published in Januar…

  7. World Health Organization call for action to eliminate cervical cancer globally 2020
    YÖKSİS SJR Q2 JCR Q2 OpenAlex top 1% OpenAlex 99.5%

    No abstract yet.

  8. Factors associated with breast cancer screening behaviours in a sample of Turkish women: A questionnaire survey 2005
    OpenAlex 86.6%

    No abstract yet.

  9. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline 2016
    YÖKSİS OpenAlex top 1% OpenAlex 99.6%

    PURPOSE: To provide evidence-based, resource-stratified global recommendations to clinicians and policymakers on the management and palliative care of women diagnosed with invasive cervical cancer. METHODS: ASCO convened a multidisciplinary, multinational panel of cancer control, medical and radiation oncology, health…

  10. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling 2021
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.2%

    BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast cancer control through short-term declines in screening and delays in diagnosis and treatments. We projected the impact of COVID-19 on future breast cancer mortality between 2020 and 2030. METHODS: Three established Cancer Intervention a…

  11. Comparative Genomics of Gardnerella vaginalis Strains Reveals Substantial Differences in Metabolic and Virulence Potential 2010
    OpenAlex top 10% OpenAlex 98.3%

    BACKGROUND: Gardnerella vaginalis is described as a common vaginal bacterial species whose presence correlates strongly with bacterial vaginosis (BV). Here we report the genome sequencing and comparative analyses of three strains of G. vaginalis. Strains 317 (ATCC 14019) and 594 (ATCC 14018) were isolated from the vag…

  12. Share Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). 2020
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 99.0%

    This paper summarises the position of ESGO and EFC on cervical screening based on existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as this offers greater protection against cervical cancer and allows longer screening intervals. Only a dozen of HPV tests are considered as clini…

Academicians

203 academicians